Immunova AI

No items found.

A finalist for the AI for Good Award, Eve leads Immunova AI, an open-source platform that combines pathology images, gene expression, and clinical data to predict cancer immunotherapy outcomes—offering a lightweight, ethical, and sustainable alternative to resource-heavy tools while making care more transparent and accessible worldwide.

Current Needs

Investor
 / 10
Philantropists
 / 10
Customers
 / 10
Business Partner
 / 10
Advisor
 / 10

Info

Business model
Company Stage
Country
Singapore

Top Challenges

No items found.

Team

Eve Ang

More projects with the same SDGS